本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Kazia Therapeutics Limited

6.38
+0.11901.90%
成交量:1,179.00
成交额:7,546.75
市值:1,065.68万
市盈率:-0.51
高:6.69
开:6.49
低:6.26
收:6.26
52周最高:30.05
52周最低:2.86
股本:167.06万
流通股本:147.79万
量比:0.27
换手率:0.08%
股息:- -
股息率:- -
每股收益(TTM):-12.3910
每股收益(LYR):-12.3910
净资产收益率:-3891.64%
总资产收益率:-63.96%
市净率:-1.97
市盈率(LYR):-0.51

数据加载中...

2021/10/07

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/09/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/22

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/04/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/04/07

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/06

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/24

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/20

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/25

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]